Pfizer and its European partner BioNTech will ask the FDA for emergency use of its vaccine for Covid-19 this Friday. The companies now claim the vaccine is 95% effective and has had few side effects, mostly fatigue and headaches. ABC reports they will have millions of doses ready to ship “within days”.
Health and Human Services Secretary Alex Azar said during a briefing Wednesday that between Pfizer's vaccine and Moderna's potential vaccine, the U.S. could have approximately 40 million doses of COVID-19 vaccines available to distribute by the end of the year.
The shots will be given to first responders and medical workers first, followed those most at risk. The plan is to give two shots 21 days apart. Pfizer claims only mild side affects. About 3.7% of those receiving the shots experienced fatigue and 2% claimed headaches.
According to the Washington Post:
The exact criteria for who will be first in line will be defined immediately after a vaccine is authorized, but the general principles have been discussed for months. You may qualify for earlier access because of your job: Health-care workers and first responders are likely to be among those prioritized. People who have essential jobs, such as teachers and food workers; those who are at higher risk because of their age; and those who have underlying conditions that increase their risk for severe disease are also likely to receive earlier access.